Polypharmacy is a widespread problem in older adults as a direct result of chronic conditions requiring an individual to take five or more daily medications. It often leads to adverse drug events that can range from mild to severe or even death. This course discusses polypharmacy, pharmacokinetics, and pharmacodynamics. It also discusses basic medication actions and interactions with a focus on the physiological changes and potential reactions seen in older adults. Understanding the pharmacokinetics and pharmacodynamics of how medications work on and within the body is important in preventing adverse drug events from polypharmacy.
Polypharmacy is a widespread problem in older adults as a direct result of chronic conditions requiring an individual to take five or more daily medications. It often leads to adverse drug events that can range from mild to severe or even death. This course discusses polypharmacy, pharmacokinetics, and pharmacodynamics. It also discusses basic medication actions and interactions with a focus on the physiological changes and potential reactions seen in older adults. Understanding the pharmacokinetics and pharmacodynamics of how medications work on and within the body is important in preventing adverse drug events from polypharmacy.
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
59A-36.011 Staff Training Requirements. Location: Online
This course is approved by the North Carolina Department of Health and Human Services Division of Facility Services - Group Care Licensure Section (NC-DHHS)
Program Sponsor ID #032316;
This activity is approved for 1.00 contact hours.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Polypharmacy
Meet Hazel
Adverse Drug Events
Defining Polypharmacy
Drug Categories
Consequences of Polypharmacy
Who Is at Risk?
Review
Summary
Section 3: Pharmacokinetics and Pharmacodynamics
Defining Terms
Pharmacokinetics
Pharmacodynamics
Medication Toxicity in Older Adults
Review
Summary
Section 4: Medication Actions and Effects
Classes of Medications
Analgesics
Anti-Infectives
Anticoagulants
Psychotropics
Antipsychotics
Anticonvulsants
Cardiovascular Medications
Diuretics
Antidiabetic Medications
Review
Summary
Section 5: Regulatory Agencies and Medication Review
Regulatory Requirements
Medication Review
Guidelines for Practice
Review
Summary
Section 6: Conclusion
Summary
Course Contributor
Kathleen is an SME Writer for the Post-Acute Care team. She has over 36 years of clinical and nursing education. She completed her Bachelor of Science in nursing from Western Governor's University. She has training from the North Carolina Statewide Program for Infection Control and Epidemiology through NCDHHS and the University of North Carolina. Kathleen has worked in long-term care, critical care, acute care, Occupational Health, and nursing education. She recently worked as a Staff Development Coordinator and Infection Control Practitioner in long-term care.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.